Bridging the treatment gap for mild and moderate anxiety and depression across E...
Each year, 25% of the EU population suffer from depression or anxiety, with higher rates for women than men. The cost of mood disorders and anxiety in the EU is about €170 billion per year. In most of the EU countries, patients wi...
Each year, 25% of the EU population suffer from depression or anxiety, with higher rates for women than men. The cost of mood disorders and anxiety in the EU is about €170 billion per year. In most of the EU countries, patients with mild and moderate anxiety and depression only get access to specialised treatment from mental health professionals when the illness become severe. In the future, the society will have major problems in providing good healthcare if we are not able prevent more: between 1990-2013 the number of people suffering from depression and/or anxiety increased by nearly 50%.
Experts emphasize that Internet-assisted treatments based on Cognitive Behavioural Therapy (ICBTs) have a great potential to improve care for mental disorders, but current solutions are having a slow adoption by health providers, mental health professionals and patients because they are very generic, do not provide controls to guarantee medical effectiveness and/or have not been designed to be used by health providers.
Explorable AS has developed the unique ICBT marketplace specially designed to be directly used by health providers. It includes an authoring tool so that practitioners at these health providers can easily create their owned ICBTs by implementing engaging technologies and gamified concepts. ICBTs will also be available to other practitioners working at other health providers. Patients only get access to ICBTs in our marketplace under the prescription of general or mental health practitioners: in that way we guarantee that patients get ICBTs with proven evidence-based therapies or best-practice methods, and they get access to specialised treatment designed by mental health professionals from the onset of their illness.
The overall objective of Mind-Gap Phase 1 is to carry out a feasibility study to verify the technological, practical and economic viability of scaling up our platform to other EU countries (market replication).ver más
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.